Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Leukapheresis × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 7 Lymphoma, B-Cell 4 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Glioblastoma 2 Ovarian Neoplasms 1 Osteosarcoma 1 Multiple Myeloma 1 Lymphoma 1 Leukemia, Lymphoid 1 Leukemia, B-Cell 1 Leukemia 1 Kidney Neoplasms 1 Hodgkin Disease 1 Glioma 1 Fallopian Tube Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 11 fludarabine 10 fludarabine phosphate 8 asciminib 7 Whole-Body Irradiation 7 Mycophenolic Acid 7 Tacrolimus 6 Melphalan 5 Busulfan 5 nilotinib 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Dasatinib 4 Imatinib Mesylate 3 Filgrastim 3 olverembatinib 2 bosutinib 2 Thiotepa 2 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Magnetic Resonance Spectroscopy 2 Cyclosporine 2 Bone Marrow Transplantation 2 venetoclax 1 treosulfan 1 thymoglobulin 1 ruxolitinib 1 ponatinib 1 blinatumomab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡